We show that these inhibitors suppress SLC15A4-mediated endolysosomal TLR and NOD features in many different human and mouse immune cells; we provide evidence in their capacity to suppress inflammation in vivo and in medical configurations; and we provide insights into their mechanism of action. Our conclusions establish SLC15A4 being https://thomasm429gpy7.oblogation.com/profile